Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 650K | Mar 10, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Chief Financial Officer |
LCTX | Lineage Cell Therapeutics, Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | Chief Financial Officer |
LCTX | Lineage Cell Therapeutics, Inc. | Jun 21, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Chief Financial Officer |
LCTX | Lineage Cell Therapeutics, Inc. | Jun 21, 2021 | 0 | $0 | 3 | Jul 1, 2021 | Chief Financial Officer |